{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T21:59:27Z","timestamp":1794261567597,"version":"4.9.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["MOHW110-TDU-B-211-124002"],"award-info":[{"award-number":["MOHW110-TDU-B-211-124002"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["109-2314-B-002-235-MY3"],"award-info":[{"award-number":["109-2314-B-002-235-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["110-2326-B-002-003-MY3"],"award-info":[{"award-number":["110-2326-B-002-003-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["110-2628-B-002-059"],"award-info":[{"award-number":["110-2628-B-002-059"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["110-S4901"],"award-info":[{"award-number":["110-S4901"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jmii.2022.09.009","type":"journal-article","created":{"date-parts":[[2022,10,2]],"date-time":"2022-10-02T17:47:10Z","timestamp":1664732830000},"page":"358-366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["In\u00a0vitro susceptibility of common Enterobacterales to eravacycline in Taiwan"],"prefix":"10.1016","volume":"56","author":[{"given":"Chun-Fu","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0924-3469","authenticated-orcid":false,"given":"Jann-Tay","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chung","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang-Huei","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee-Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2022.09.009_bib1","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.2147\/IDR.S337611","article-title":"Emerging carbapenem-resistant Enterobacterales infection, its epidemiology and novel treatment options: a review","volume":"14","author":"Tilahun","year":"2021","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jmii.2022.09.009_bib2","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jmii.2022.09.009_bib3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejmech.2017.03.022","article-title":"Recent updates of carbapenem antibiotics","volume":"131","author":"El-Gamal","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jmii.2022.09.009_bib4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drup.2016.09.002","article-title":"The rapid spread of carbapenem-resistant Enterobacterales","volume":"29","author":"Potter","year":"2016","journal-title":"Drug Resist Updates"},{"key":"10.1016\/j.jmii.2022.09.009_bib5","article-title":"Carbapenem-resistant Enterobacterales in long-term care facilities: a global and narrative review","volume":"11","author":"Chen","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jmii.2022.09.009_bib6","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1093\/cid\/ciaa1478","volume":"72","author":"Tamma","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2022.09.009_bib7","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/jac\/dki248","volume":"56","author":"Pankey","year":"2005","journal-title":"Tigecycline. J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2022.09.009_bib8","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/cid\/ciz394","article-title":"Omadacycline: a modernized tetracycline","volume":"69","author":"Gallagher","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2022.09.009_bib9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s40265-019-01067-3","article-title":"Eravacycline: a review in complicated intra-abdominal infections","volume":"79","author":"Scott","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.jmii.2022.09.009_bib10","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/AAC.01242-13","article-title":"In\u00a0vitro and in\u00a0vivo antibacterial activities of omadacycline, a novel aminomethylcycline","volume":"58","author":"Macone","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2022.09.009_bib11","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/cid\/ciy1029","article-title":"IGNITE4: results of a phase 3, randomized, multicenter, prospective trial of eravacycline vs meropenem in the treatment of complicated intraabdominal infections","volume":"69","author":"Solomkin","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2022.09.009_bib12","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1089\/sur.2020.241","article-title":"Efficacy and tolerability of eravacycline in bacteremic patients with complicated intra-abdominal infection: a pooled analysis from the IGNITE1 and IGNITE4 studies","volume":"22","author":"Felice","year":"2021","journal-title":"Surg Infect"},{"key":"10.1016\/j.jmii.2022.09.009_bib13","first-page":"16999","article-title":"In\u00a0vitro activity of eravacycline against gram-negative bacilli isolated in clinical laboratories worldwide from 2013 to 2017","volume":"64","author":"Morrissey","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2022.09.009_bib14","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1128\/AAC.00436-16","article-title":"In\u00a0vitro activity of eravacycline against carbapenem-resistant Enterobacterales and acinetobacter baumannii","volume":"60","author":"Livermore","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2022.09.009_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106178","article-title":"In\u00a0vitro activity of eravacycline compared with tigecycline against carbapenem-resistant Enterobacterales","volume":"56","author":"Clark","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2022.09.009_bib16","volume":"58","author":"Lee","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2022.09.009_bib17","series-title":"Performance standards for antimicrobial susceptibility testing: 31th informational supplement, M100S","year":"2021"},{"key":"10.1016\/j.jmii.2022.09.009_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145823","article-title":"Co-carriage of blaKPC-2 and blaNDM-1 in clinical isolates of Pseudomonas aeruginosa associated with hospital infections from India","volume":"10","author":"Paul","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jmii.2022.09.009_bib19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.diagmicrobio.2010.12.002","article-title":"Multiplex PCR for detection of acquired carbapenemase genes","volume":"70","author":"Poirel","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2022.09.009_bib20","series-title":"Breakpoint tables for interpretation of MICs and zone diameters, version 11.0","year":"2021"},{"key":"10.1016\/j.jmii.2022.09.009_bib21","series-title":"Omadacycline\u2013injection products. FDA- identified interpretive criteria","first-page":"18","year":"2019"},{"key":"10.1016\/j.jmii.2022.09.009_bib22","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","article-title":"Correlation coefficients: appropriate use and interpretation","volume":"126","author":"Schober","year":"2018","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jmii.2022.09.009_bib23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1016\/j.jmii.2022.09.009_bib24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/microbiolspec.UTI-0017-2013","article-title":"Proteus mirabilis and urinary tract infections","volume":"3","author":"Schaffer","year":"2015","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jmii.2022.09.009_bib25","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1128\/AAC.47.2.665-669.2003","article-title":"AcrAB multidrug efflux pump is associated with reduced levels of susceptibility to tigecycline (GAR-936) in","volume":"47","author":"Visalli","year":"2003","journal-title":"Proteus mirabilis. Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2022.09.009_bib26","doi-asserted-by":"crossref","first-page":"a025387","DOI":"10.1101\/cshperspect.a025387","article-title":"Tetracycline antibiotics and resistance","volume":"6","author":"Grossman","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"10.1016\/j.jmii.2022.09.009_bib27","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.3390\/pharmaceutics13122085","article-title":"The development of third-generation tetracycline antibiotics and new perspectives","volume":"13","author":"Rusu","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jmii.2022.09.009_bib28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jhin.2010.05.001","article-title":"Secular trends of healthcare-associated infections at a teaching hospital in Taiwan, 1981-2007","volume":"76","author":"Chuang","year":"2010","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jmii.2022.09.009_bib29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/phar.2366","article-title":"Evaluation of eravacycline: a novel fluorocycline","volume":"40","author":"Alosaimy","year":"2020","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jmii.2022.09.009_bib30","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1128\/JCM.01782-06","article-title":"Comparison of disk diffusion, VITEK 2, and broth microdilution antimicrobial susceptibility test results for unusual species of Enterobacterales","volume":"45","author":"Stone","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmii.2022.09.009_bib31","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s10096-020-04123-z","volume":"40","author":"Yin","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2022.09.009_bib32","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1093\/jac\/dks288","article-title":"In\u00a0vitro susceptibility of multidrug-resistant Enterobacterales clinical isolates to tigecycline","volume":"67","author":"Huang","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2022.09.009_bib33","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/jac\/dkab141","article-title":"In\u00a0vitro activity of imipenem\/relebactam, meropenem\/vaborbactam, ceftazidime\/avibactam, cefepime\/zidebactam and other novel antibiotics against imipenem-non-susceptible Gram-negative bacilli from Taiwan","volume":"76","author":"Kuo","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2022.09.009_bib34","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1086\/367622","article-title":"Tetracycline therapy: update","volume":"36","author":"Roberts","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2022.09.009_bib35","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/microbiolspec.VMBF-0016-2015","article-title":"Mechanisms of antibiotic resistance","volume":"4","author":"Munita","year":"2016","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jmii.2022.09.009_bib36","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s15010-021-01735-1","article-title":"Epidemiology and in\u00a0vitro activity of ceftazidime-avibactam, meropenem-vaborbactam, imipenem-relebactam, eravacycline, plazomicin, and comparators against Greek carbapenemase-producing Klebsiella pneumoniae isolates","volume":"50","author":"Maraki","year":"2022","journal-title":"Infection"},{"key":"10.1016\/j.jmii.2022.09.009_bib37","article-title":"Tigecycline susceptibility and the role of efflux pumps in tigecycline resistance in KPC-producing Klebsiella pneumoniae","volume":"10","author":"He","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jmii.2022.09.009_bib38","doi-asserted-by":"crossref","first-page":"10079","DOI":"10.3390\/ijerph120810079","article-title":"Prevalence of genes of OXA-23 carbapenemase and AdeABC efflux pump associated with multidrug resistance of acinetobacter baumannii isolates in the ICU of a comprehensive hospital of northwestern China","volume":"12","author":"Jia","year":"2015","journal-title":"Int J Environ Res Publ Health"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118222001608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118222001608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:30:26Z","timestamp":1761658226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118222001608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1684118222001608"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2022.09.009","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In\u00a0vitro susceptibility of common Enterobacterales to eravacycline in Taiwan","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2022.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}